Artgen Biotech PJSC Cash Flow Statement

Financials in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	96.95	214.91	168.86	46.12	11.63
Depreciation & Amortization	142.08	84.35	70.9	53.48	79.84
Other Amortization	-	0.36	-	-	1.44
Loss (Gain) From Sale of Assets	0.92	-0.52	0.58	75.31	26.51
Loss (Gain) on Equity Investments	25.97	3.5	24.17	-23.14	5.21
Provision & Write-off of Bad Debts	8.29	11.98	13.43	15.41	12.73
Other Operating Activities	25.52	234.66	112.13	84.91	99.99
Change in Accounts Receivable	-153.54	-28.52	-92.46	86.7	8.72
Change in Inventory	22.13	-21.58	-1.51	16.4	-21.54
Change in Accounts Payable	22.43	-17.32	138.75	-134.9	56.27
Operating Cash Flow	190.75	481.83	434.85	220.3	280.8
Operating Cash Flow Growth	-60.41%	10.80%	97.39%	-21.55%	421.32%
Capital Expenditures	-170.39	-99.68	-204.29	-135.93	-153.3
Cash Acquisitions	-25.58	-4.88	-	-78.96	-
Investment in Securities	-5.18	-0.17	-46.86	-66.1	-71.49
Other Investing Activities	59.5	52.55	27.04	5.48	6.12
Investing Cash Flow	-288.25	-171.31	-216.97	-346.78	-252.25
Long-Term Debt Issued	300	-	-	196	319.23
Long-Term Debt Repaid	-70.4	-122.78	-83.76	-14.19	-194.64
Net Debt Issued (Repaid)	229.6	-122.78	-83.76	181.81	124.59
Issuance of Common Stock	14.12	-	38.89	43.8	3.49
Repurchase of Common Stock	-	-35.96	-	-	-
Common Dividends Paid	-56.21	-140.69	-104.23	-	-
Other Financing Activities	-29.68	-47.31	274.03	-87.3	-69.11
Financing Cash Flow	157.83	-346.74	124.94	138.31	58.96
Foreign Exchange Rate Adjustments	1.69	-5.38	0.46	-3.46	-1.61
Miscellaneous Cash Flow Adjustments	-	-	-	0	-
Net Cash Flow	62.02	-41.59	343.28	8.37	85.9
Free Cash Flow	20.36	382.16	230.56	84.37	127.51
Free Cash Flow Growth	-94.67%	65.75%	173.26%	-33.83%	-
Free Cash Flow Margin	1.19%	25.12%	16.85%	7.42%	10.80%
Free Cash Flow Per Share	0.27	4.13	2.49	0.97	1.59
Cash Interest Paid	-	91.35	52.1	48.6	50.71
Cash Income Tax Paid	-	5.8	24.64	3.83	5.71
Levered Free Cash Flow	-294.76	158.46	-28.18	-139.31	-12.27
Unlevered Free Cash Flow	-238.67	217.87	2.59	-96.92	19.4
Change in Working Capital	-108.98	-67.42	44.78	-31.79	43.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.